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Synthesis and utilization of messenger RNA (mRNA) is
central to the determination of cellular characteristics. mRNA
comprises cytoplasmic polynucleotides of approximately 1.5 kd
that contain information coding for the polypeptides synthe-
sized by a cell [1, 2]. mRNAs derive from high molecular weight
precursors transcribed, capped, and polyadenylated in the
nucleus [3]. Subsequent nuclear-splicing reactions excise non-
coding intervening sequences selectively [4] and place the
triplet codons of the finally processed molecules into the
sequence and reading frame essential for accurate translation
into protein [5, 6]. The last step in protein synthesis involving
mRNA directly is the translation of mRNA nucleotide sequence
into the primary structure of the corresponding protein [7].
Since cell (and organ) phenotype results from the sum of
nuclear synthesis and cytoplasmic utilization of specific
mRNAs, regulation of cell function during periods of physiolog-
ic change probably is mediated in part by quantitative and
qualitative alterations in mRNA metabolism. Each process
outlined above may be subject to control.
Mammalian mRNAs have common structural features includ-
ing caps, polyadenylate, noncoding sequences, and associated
proteins [3]. First, the 5' ends of mRNA terminate in cap
structures consisting of 7-methyl-guano sine linked to the penul-
timate nucleotide by a triphosphate bridge [8]. Although unes-
sential for protein synthesis [9], caps enhance the efficiency of
translational initiation [10, 11]. Second, the 3' terminus general-
ly ends in a homopolymer of 30 to 180 adenylate residues,
termed poly(A), which are added immediately after transcrip-
tion ceases [12]. Poly(A) apparently stabilizes the mRNA
lifetime [13, 14] and has provided a marker for mRNA purifica-
tion [15]. Third, mRNAs exceed the minimum number of
nucleotides necessary to code for protein by 10 to 50% [16]; the
additional sequences occupy positions between the cap and the
initiating codon and between the termination codon and the
polyadenylation site. Functions for noncoding sequences in
positioning mRNA for accurate initiation and termination of
translation have been suggested. Fourth, mRNAs are not found
as naked polynucleotide strands but exist instead in the form of
cytoplasmic ribonucleoproteins (RNP) [17—19], 20 to 60% of
which are recovered as nonpolysomal, free messenger RNP
(mRNPs) [20—24].
Renal mRNA shares the common features of other mammali-
an mRNAs and exhibits heterogeneity with respect to lifetime,
polyadenylation, cytoplasmic distribution, translational activi-
ty, and apparent membrane association [25—30]. This heteroge-
neity underscores the complexity of analyzing regulation of
mRNA mixtures during adaptation to the loss of renal mass. In
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this report, the heterogeneity of kidney mRNA will be de-
scribed and discussed with respect to problems posed to the
study of mRNA regulation during compensatory renal
hypertrophy.
Methods
Animals and labeling. Male mice (45 days old, 30 to 35 g)
from Charles River Breeding Laboratories, Inc., North Wil-
mington, Massachusetts, were housed under alternating 12-hr
cycles of light and dark and fed ad libitum.
Subcellular fractionation and preparation of mRNA. Decap-
sulated mouse kidneys were disrupted by Dounce homogeniza-
tion in ice-cold buffer consisting of 10 mrvt Tris-HC1 (pH 7.4),
0.25 M sucrose, 0.15 M NaC1, and 3 mrvi MgC12 (two kidneys per
milliliter of buffer). Nominal postmitochondrial supematants
prepared by centrilugation of homogenates at 9000 rpm for 10
mm in the Sorvall SS-34 rotor were sedimented in 36 ml of 7 to
47% (w/w) sucrose density gradients containing 10 mri Tris-HC1
(pH 7.4), 0.50 M NaCl, and 50 mM MgC12 for 3 hr at 25,500 rpm
in the SW27 rotor at 4°C. Deproteinized RNA [30, 31] was
separated into poly(A)-containing and poly(A)-deficient classes
by oligo(dT)-cellulose chromatography [321.
mRNA-directed cell-free translation. mRNA was translated
in vitro using the rabbit reticulocyte lysate [33]. Amino acid
incorporation was assayed as alkali-stable, acid-insoluble radio-
activity in l-j.d samples. Translation products were analyzed in
linear 6 to 15% gradient polyacrylamide slab gels (1.5 mm) [34].
Results
To elucidate the general pattern of renal mRNA regulation,
the lifetime, polyadenylation, cytoplasmic distribution, and
cytoplasmic mRNA in mouse kidney have been described [25—
30]. As shown by the following experiments, renal mRNA in the
mouse exhibits heterogeneity with respect to each of these
properties. An understanding of this structural and functional
heterogeneity is essential to a complete understanding of
mRNA regulation during compensatory growth of the kidney.
Cytoplasmic distribution of mouse kidney mRNA. A large
fraction of renal mRNA exists apart from the translational
apparatus. As the first step toward describing renal mRNA,
mouse kidney cytoplasm was fractionated in sucrose density
gradients to define the structures with which mRNA is associat-
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Fig. 1. Nonpolysomal renal mRNA. A Sedimentation of mouse kidney
cytoplasm. Postmitochondriai supernatant was centrifuged in a 36-mi
linear 7 to 47% sucrose density gradient at 4°C for 3 hr at 26,500 rpm in
the Beckman SW27 rotor. Absorbance of light at 260 nm was monitored
continuously while the gradient was fractionated. Region A: poly-
somes, RNP> 100 S; region B: nonpolysomal RNP 20 to 100 S; region
C: RNP < 20 S. B [35SJmethionine-labeled translation products of
polysomal (left lane) and nonpolysomal (right lane) mRNAs separated
in polyacrylarnide gels (Methods). Bars at left denote molecular weight
markers phosphorylase A (92 kd), ovalbumin (45 kd), and chymotryp-
sinogen (24.5 kd). C Translational activity of polysomal and nonpolyso-
mal renal mRNA measured in reaction mixtures (50 p,lfinal volume) of
the respective poly(Ai mRNAs (20 ngl,ul) incubated at 37°C. Incorpo-
ration of [3H]leucine into mRNA-directed polypeptides was assayed
(Methods) in 5-,al samples removed at the times shown.
ed (Fig. 1A). Approximately 20 to 25% of cytoplasmic poly(A)-
containing [poly(A)J mRNA is nonpolysomal in that it is not
found in > 80 S polyribosome translation structures (region A,
Fig. lÀ) but instead sediments as free 20 to 100 S mRNP (region
B, Fig. IA) [30]. Therefore, at the time of cell disruption, one
fourth of poly(A)1 mRNA in the kidney is not active in
translation. Similar cytoplasmic distributions have been report-
ed for mRNA in cultured mammalian cells [20—24]. This cyto-
plasmic distribution of poly(A)* mRNA is observed for steady-
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[3H]poly(U) and by light absorption at 260 nm, and for newly
synthesized poly(AY mRNA measured by quantitation of
radioactivity [301. Kinetic labeling experiments showed that
newly synthesized polysomal mRNA enters the cytoplasm
through the nonpolysomal mRNP pooi, but the similar turnover
rates and specific activities (cpm/Lg RNA) of labeled poly(A)
mRNA from these fractions indicated that polysomal and non-
polysomal RNA are in rapid equilibrium. The kinetics of
polysomal and nonpolysomal poly(A) mRNA labeling and
decay are inconsistent with the accumulation and sequestration
of many nonpolysomal mRNAs unique to that cell fraction [30].
Polysomal and nonpolysomal renal mRNAs are not distin-
guishable with regard to sequence content or products coded in
a cell-free translation system. To test whether nonpolysomal
mRNA codes for fewer or for different proteins than polysomal
mRNA, the homology and nucleotide complexity of these
mRNAs and their mRNA-directed cell-free translation products
were compared [30]. When measured by saturation hybridiza-
tion to radiolabeled single copy mouse DNA [35], the number of
different mRNAs in these mRNA fractions were found to be
similar and to correspond to 40,000 different mRNA se-
quences [30]. Moreover, since total cytoplasmic poly(A)
RNA, polysomal poly(A) mRNA, and nonpolysomal poly(A)
mRNA have equivalent numbers of mRNAs, mRNAs found in
polysomes all appear to be represented in nonpolysomal mRNA
[30] within the accuracy of the measurements. Other nucleic
acid hybridization experiments demonstrated that the relative
concentration of mRNA sequences was similar in polysomal
and nonpolysomal mRNA [301. Cell-free synthesized polypep-
tides coded by translationally active polysomal and nonpolyso-
mal mRNAs were the same with the exception of a single band
at - 15 kd apparently coded only by polysomal mRNA (Fig.
1B). The identity of this apparently polysome-specific transla-
tion product is unknown, but regulation of its mRNA is of
interest for its high translational efficiency and for its high
relative abundance in polysomes.
In the reticulocyte lysate cell-free translation system, non-
polysomal mRNA translates at only — 25% the rate and extent
of polysomal mRNA (Fig. lC). Thus, despite the extensive
homology these mRNAs show in other respects, mRNAs from
nonpolysomal mRNP are relatively inefficient translationally on
a unit mass basis. Studies using m7GMP, an analogue of capped
5' mRNA termini that inhibits translation of capped mRNA
selectively, indicated a higher frequency of cap deficient mole-
cules in nonpolysomal mRNA [30], a feature consistent with
reduced template activity [36—38]. Furthermore, guanyltrans-
ferase, the cap repair enzyme, catalyzed 2.5 times greater
incorporation of [3H]GTP into nonpolysomal poly(A) mRNA
than that into polysomal mRNA (not shown). Since the prod-
ucts of polysomal and nonpolysomal mRNA translation are so
similar, we conclude that renal mRNAs coding for the same
polypeptide may exhibit variable translational activity; mole-
cules with reduced translational efficiency would initiate trans-
lation slowly and accumulate in 20 to 100 S nonpolysomal
mRNP.
Poly(A)-deficient mRNA in mouse kidney. Approximately
one hail of newly synthesized renal mRNA lacks poly(A) or
terminates in a poly(A) length insufficient to permit binding to
oligo(dT)-cellulose or poly(U)Sepharose [28, 39]. The polyad-
enylation state of renal mRNA was investigated under condi-
tions that inhibit cytoplasmic appearance of ribosomal RNA but
permit synthesis and accumulation of mRNA to continue at the
normal rate [28, 29]. Only 40 to 50% of newly synthesized renal
mRNA contained sufficient poly(A) for retention on poly(A)
affinity columns [28, 39]. Unlike mouse brain which contains an
equivalent fraction of poly(A)-lacking mRNA distinct from
poly(A)-containing mRNA [35], poly(A)-deficient mRNA in
mouse kidney contains no measureable nucleotide complexity
above that in poly(AY mRNA or total cytoplasmic RNA [28].
Since the number of mRNAs in these RNA populations is
equivalent, poly(A) mRNA and poly(A)-deficient mRNA con-
sist of the same sequences in the kidney. Moreover, poly(A)-
deficient and poly(A) mRNAs occur in similar relative abun-
dance and code for the same cell-free synthesized polypeptides
[28]. Thus, renal mRNA shows heterogeneity in extent of
polyadenylation as well as variable translational efficiency.
Membrane association of a fraction ofpoly(A)-deficient renal
mRNA. Further heterogeneity in renal mRNA was shown with
the demonstration that a large fraction of poly(A)-deficient
mRNA in mouse kidney associates with membranes in a
manner not exhibited by poly(A) mRNA. In Mg k-containing
sucrose density gradients which preserve polysome structure,
newly synthesized poly(AY and poly(A)-deficient mRNA have
the same distribution in polysomal mRNP (75%) and nonpoly-
somal mRNP (25%) [29]. However, in the presence of EDTA
which disrupts polysomes into ribosomal subunits and free
mRNP, although 95% of poly(A) mRNA was released from
disaggregated polysomes into 20 to 80 S mRNP as expected,
only 50% of poly(A)-deficient mRNA was released in the same
gradient [291. The remaining 50% of poly(A)-deficient mRNA
stayed in structures that continued to sediment rapidly even
after polysomes were disaggregated totally. Membrane associ-
tion of poly(A)-deficient mRNA in these EDTA-resistant parti-
cles was demonstrated by the fact that treatment of cytoplasm
with a nonionic detergent which solubilizes membranes re-
leased 70% of this poly(A)-deficient mRNA fraction into the 20
to 80 5 mRNP region [29]. That poly(A)-deficient mRNAs on
membranes may be localized or compartmentalized primarily to
code for membrane proteins is purely speculative at this time.
mRNA in compensatory renal hypertrophy. Analyses of total
mRNA during renal growth have not detected change in the
size, cytoplasmic distribution, lifetime, and translation prod-
ucts of apparent sequence content of renal mRNA during
compensatory hypertrophy [29—40]. Nevertheless, the approxi-
mate doubling of ribosome content in proximal tubular cells in
the first 24 to 36 hr after uninephrectomy is unlikely to proceed
without quantitative and qualitative changes in the cellular
mRNA or without alterations in the normal pattern of mRNA
metabolism.
Explanations for the difficulty in detecting regulatory change
include the heterogeneity of the renal mRNA population as
described above [25—30], the periods during the growth re-
sponse selected for investigation, and the application of meth-
ods suited mainly to analysis of abundant mRNAs. First, in
vivo radiolabeling gives rise to radioactive RNA preparations in
which individual mRNAs constitute a very small fraction
(<0.1%) of the total labeled population, and regulatory change
in one or only a few sequences probably would be masked by
the majority of mRNAs whose metabolism in growth remained
normal. Second, unless sampling begins within the first hour





Fig. 2. Cell-free synthesized polypeptides directed by mRNAs from
growing kidney. [35S]methionine-labeled translation products were sep-
arated in a polyacrylamide gel (Fig. IB, Methods). Lanes: A, no mRNA;
B to F, products directed by mRNA from remaining kidney 1, 2.5, 4, 7,
and 18 hr after nephrectoniy, respectively; G, products of control
kidney mRNA.
after uninephrectomy and sampling is frequent and at closely
spaced intervals, early but transient events of importance
certainly would be missed. Therefore, the absence of growth-
specific alterations reported in renal mRNAs prepared 24 hr and
4 days after contralateral nephrectomy indeed may be correct
but still must be considered incomplete [40]. Similarly, compar-
isons of renal mRNA from growing and nongrowing kidney by
analysis of cell-free translation products and by cDNA hybrid-
ization provide accurate comparisons of abundant mRNAs
only. Changes in mRNAs of intermediate or low intracellular
concentration would have gone undetected in most experiments
performed to date.
Early in compensatory hypertrophy the pattern of mRNA
metabolism becomes altered in that the amount of polyadenyl-
ated mRNA relative to poly(A)-deficient mRNA changes 1271.
Within an hour of unilateral nephrectomy, the fraction of
newly-synthesized poly(A)-deficient mRNA increases by al-
most 25%. This alteration in extent of polyadenylation of newly
synthesized mRNA is not an artifact of increased ribonuclease
induced by growth because the size of these mRNAs is un-
changed during growth, and because the fraction of radioactiv-
ity in polyadenylated mRNA remains normal when kidneys are
labeled before uninephrectomy [271. The latter observation
further demonstrates that pre-existing mRNA molecules are not
involved in the regulatory change. The importance of this
observation is still unclear, since poly(AY and poly(A)-defi-
cient renal mRNAs share extensive homology in normal kidney
[281.
Analysis of cell-free translation products coded by renal
mRNAs prepared at times in the first 24 hr postnephrectomy
failed to show new, abundant mRNAs during this period of
RNA accretion (Fig. 2). These results complement and are
consistent with those of other investigators comparing mRNA
from normal kidneys with that from remaining kidneys 4 days
alter uninephrectomy in which quantitative changes in renal
mRNA were associated with hypertrophy without the appear-
ance of new mRNAs [40]. Thus, the general pattern of mRNA
metabolism is altered during renal hypertrophy without detect-
able qualitative changes in abundant translatable mRNAs.
However, as Miller and McCarthy indicate, growth-induced
changes in expression of genes encoding low abundance
mRNAs would not have been detected by these experiments
[40].
Discussion
The understanding of mRNA in mouse kidney and its regula-
tion during compensatory renal hypertrophy can be summa-
rized as follows. Renal mRNA is heterogeneous with respect to
lifetime [25—26], polyadenylation state [28, 39], cytoplasmic
distribution [301, translational activity [301, and association with
intracellular membranes [29]. In the first hours following
nephrectomy, the fraction of poly(A)-deficient mRNA rises by
25%, but the lifetime and cytoplasmic distribution of mRNA
remain constant during growth [27]. The relative abundance of
some undefined renal mRNAs appears to change between days
1 and 4 after nephrectomy [40]. Despite these differences in the
general pattern of mRNA metabolism, new growth-specific
mRNAs have not been detected and the metabolic pattern of
individual mRNA sequences has not been investigated.
One difficulty with many studies of mRNA regulation during
growth induction (including our own) stems from the use of cell-
free translation and molecular hybridization employing cDNA
prepared to total poly(A) mRNA. Because the frequency of in
vitro mRNA reverse transcription is proportional to mRNA
abundance, cDNAs are synthesized in accordance with the
frequency of individual template mRNAs. As a result, cDNA
hybridization analyses are limited primarily to abundant and
middle abundant mRNAs, and provide for accurate consider-
ation of only a small fraction of the 10,000 to 30,000 different
mRNAs in the cytoplasm. Moreover, cDNAs synthesized by
conventional procedures have poly(A) as a requirement for
transcription and fail to include the 50% of renal mRNA that is
poly(A)-deficient. A similar limitation exists for comparisons of
mRNA-directed cell-free translation products in which fewer
than 400 to 600 in vitro-synthesized polypeptides can be distin-
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Table 1. Summary of renal mRNA heterogeneity
Property Description Reference
Size 800 to 4500 nucleotides 26, 40, 47
Lifetime 1 hr to >24 hr 25, 26
Cytoplasmic distribution 25% in nonpolysomal
mRNP
30, 48
Polyadenylation 50% is poly(A) mRNA 28, 39











Sequences range from 1
to 10,000 copies per
cell
28, 40, 46, 47
Abbreviations: mRNA,
ribonucleoprotein.
messenger RNA; mRNP, messenger
guished under the best of conditions. Therefore, it is clear that
alternative approaches to these experiments will be necessary
in future examinations of the metabolism and regulation of rare
copy mRNAs which constitute most of the diversity in cellular
mRNA. Assuming the existence of proteins that regulate mam-
malian gene expression and growth, it seems their correspond-
ing mRNAs would not be required at abundant levels and thus
would not occur at levels detectable in previous studies.
That recombinant DNA techniques have advanced the under-
standing of mammalian gene regulation is an unabashed truism,
but nevertheless the application of recombinant DNA technolo-
gy to investigate genetic regulation during compensatory hyper-
trophy is certain to define renal growth at the molecular level.
The insertion of DNA sequences into bacterial plasmids fol-
lowed by selective growth of transfected plasmid-bearing bacte-
rial hosts provides for the isolation of clones containing inserted
DNA sequences of genomic origin or enzymatically copied
from mRNA [41—43]. Procedures for detection of clones corre-
sponding to rare copy mRNAs have been reported and used to
study the developmental regulation of such mRNA sequences
in chick muscle at great sensitivity [44]. Application of these
methods to investigate renal growth will provide descriptions of
the structure, sequence, and growth-induced activity or alter-
ation of genes whose products will be unknown at first [45]. In
the early stages, identification of these genes may be less
important and relevant than the information obtained from their
analysis. The activity of such genes in nongrowing kidney,
during induced renal growth, during growth of fetal and neona-
tal kidney, and in kidney and organs of other species all are
measurable with existing methodology. The study of these
genes, even lacking their identity, during growth still will
provide descriptive information essential to the elucidation of
molecular mechanisms involved in the regulation of normal
organ growth and development.
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Summary. The normal pattern of mRNA metabolism almost
certainly becomes altered after uninephrectomy, especially
during the first day when ribosomes accumulate in the proximal
tubular cells of the remaining kidney. For example, within the
first hour after nephrectomy, the fraction of newly synthesized
poly(A)-deficient mRNA increases relative to poly(A)-contain-
ing mRNA. Investigation of other growth-specific regulatory
changes in renal mRNA has been complicated by its heteroge-
neity with respect to translational activity, polyadenylate con-
tent, membrane association, and cytoplasmic distribution (Ta-
bles 1 and 2). In general, analysis of kidney mRNA metabolism
during growth has not been sufficiently thorough in that few
timepoints have been examined after nephrectomy and the
techniques used have been suited primarily to the study of only
abundant mRNA sequences. Application of recombinant DNA
methods should eliminate these difficulties and permit quantita-
tive measurement of growth-specific genetic events during
compensatory growth of the kidney.
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